Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole

Judith-Anne W. Chapman, Jane Bayani, Sandip SenGupta, John M. S. Bartlett, Tammy Piper, Mary Anne Quintayo, Shakeel Virk, Paul E. Goss, James N. Ingle, Matthew J. Ellis, George W. Sledge, G. Thomas Budd, Manuela Rabaglio, Rafat H. Ansari, Richard Tozer, David P. D’Souza, Haji Chalchal, Silvana Spadafora, Vered Stearns, Edith A. Perez, Karen A. Gelmon, Timothy J. Whelan, Catherine Elliott, Lois E. Shepherd, Bingshu E. Chen, Karen J. Taylor

Open source

DOI: 10.1007/s10549-025-07749-9
Published: 2025-06-23
Container: Breast Cancer Research and Treatment
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-025-07749-9,
  title = {Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole},
  author = {Judith-Anne W. Chapman and Jane Bayani and Sandip SenGupta and John M. S. Bartlett and Tammy Piper and Mary Anne Quintayo and Shakeel Virk and Paul E. Goss and James N. Ingle and Matthew J. Ellis and George W. Sledge and G. Thomas Budd and Manuela Rabaglio and Rafat H. Ansari and Richard Tozer and David P. D’Souza and Haji Chalchal and Silvana Spadafora and Vered Stearns and Edith A. Perez and Karen A. Gelmon and Timothy J. Whelan and Catherine Elliott and Lois E. Shepherd and Bingshu E. Chen and Karen J. Taylor},
  year = {2025},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-025-07749-9},
  url = {https://doi.org/10.1007/s10549-025-07749-9}
}

RIS

TY  - JOUR
TI  - Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole
AU  - Judith-Anne W. Chapman
AU  - Jane Bayani
AU  - Sandip SenGupta
AU  - John M. S. Bartlett
AU  - Tammy Piper
AU  - Mary Anne Quintayo
AU  - Shakeel Virk
AU  - Paul E. Goss
AU  - James N. Ingle
AU  - Matthew J. Ellis
AU  - George W. Sledge
AU  - G. Thomas Budd
AU  - Manuela Rabaglio
AU  - Rafat H. Ansari
AU  - Richard Tozer
AU  - David P. D’Souza
AU  - Haji Chalchal
AU  - Silvana Spadafora
AU  - Vered Stearns
AU  - Edith A. Perez
AU  - Karen A. Gelmon
AU  - Timothy J. Whelan
AU  - Catherine Elliott
AU  - Lois E. Shepherd
AU  - Bingshu E. Chen
AU  - Karen J. Taylor
PY  - 2025
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-025-07749-9
UR  - https://doi.org/10.1007/s10549-025-07749-9
ER  -

APA

Chapman, J. W., Bayani, J., SenGupta, S., Bartlett, J. M. S., Piper, T., Quintayo, M. A., Virk, S., Goss, P. E., Ingle, J. N., Ellis, M. J., Sledge, G. W., Budd, G. T., Rabaglio, M., Ansari, R. H., Tozer, R., D’Souza, D. P., Chalchal, H., Spadafora, S., Stearns, V., Perez, E. A., Gelmon, K. A., Whelan, T. J., Elliott, C., Shepherd, L. E., Chen, B. E., & Taylor, K. J. (2025). Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07749-9

Source records

crossref · retrieved 2026-09-26T17:32:23.088Z